Search Results - "Bates, Olivia"

Climatic niche shifts in introduced species by Bates, Olivia K., Bertelsmeier, Cleo

“…Predictions of future biological invasions often rely on the assumption that introduced species establish only under climatic conditions similar to those in…”
Get full text

Smaller climatic niche shifts in invasive than non-invasive alien ant species by Bates, Olivia K., Ollier, Sébastien, Bertelsmeier, Cleo

“…The globalization of trade and human movement has resulted in the accidental dispersal of thousands of alien species worldwide at an unprecedented scale. Some…”
Get full text

Molecular Anatomy of the Developing Human Retina by Hoshino, Akina, Ratnapriya, Rinki, Brooks, Matthew J., Chaitankar, Vijender, Wilken, Matthew S., Zhang, Chi, Starostik, Margaret R., Gieser, Linn, La Torre, Anna, Nishio, Mario, Bates, Olivia, Walton, Ashley, Bermingham-McDonogh, Olivia, Glass, Ian A., Wong, Rachel O.L., Swaroop, Anand, Reh, Thomas A.

“…Clinical and genetic heterogeneity associated with retinal diseases makes stem-cell-based therapies an attractive strategy for personalized medicine. However,…”
Get full text

Global flows of insect transport and establishment: The role of biogeography, trade and regulations by Fenn-Moltu, Gyda, Ollier, Sébastien, Bates, Olivia K., Liebhold, Andrew M., Nahrung, Helen F., Pureswaran, Deepa S., Yamanaka, Takehiko, Bertelsmeier, Cleo

“…Abstract Aim Non‐native species are part of almost every biological community worldwide, yet numbers of species establishments have an uneven global…”
Get full text

Increased acclimation ability accompanies a thermal niche shift of a recent invasion by Bujan, Jelena, Charavel, Ellouène, Bates, Olivia K., Gippet, Jérôme M. W., Darras, Hugo, Lebas, Claude, Bertelsmeier, Cleo, Resasco, Julian

“…Globalization is removing dispersal barriers for the establishment of invasive species and enabling their spread to novel climates. New thermal environments in…”
Get full text

Engineering resistance to CD33-targeted immunotherapy in normal hematopoiesis by CRISPR/Cas9-deletion of CD33 exon 2 by Humbert, Olivier, Laszlo, George S., Sichel, Sophie, Ironside, Christina, Haworth, Kevin G., Bates, Olivia M., Beddoe, Mary E., Carrillo, Ray R., Kiem, Hans-Peter, Walter, Roland B.

Get full text

Bumble bees strategically use ground level linear features in navigation by Brebner, Joanna S., Makinson, James C., Bates, Olivia K., Rossi, Natacha, Lim, Ka S., Dubois, Thibault, Gómez-Moracho, Tamara, Lihoreau, Mathieu, Chittka, Lars, Woodgate, Joseph L.

“…Extended ground level structures like roads or field edges can be important cues for navigating animals, seen for example in road-following pigeons. In a…”
Get full text

Preparing to eradicate a novel invader of unknown biology: a case study from Australia by Hoffmann, Benjamin, Widmer, Marc, Bates, Olivia

“…Although there have been many attempts at eradicating exotic ant incursions, most efforts have been unsuccessful, and a lack of specific biological knowledge…”
Get full text

The global risk of infectious disease emergence from giant land snail invasion and pet trade by Gippet, Jérôme M W, Bates, Olivia K, Moulin, Jérémie, Bertelsmeier, Cleo

“…Abstract Background Pathogen outbreaks mostly originate from animals, but some species are more likely to trigger epidemics. The giant land snail (…”
Get full text

Simultaneous multiple interaction T-cell engaging (SMITE) bispecific antibodies overcome bispecific T-cell engager (BiTE) resistance via CD28 co-stimulation by Correnti, Colin E., Laszlo, George S., de van der Schueren, Willem J., Godwin, Colin D., Bandaranayake, Ashok, Busch, Melanie A., Gudgeon, Chelsea J., Bates, Olivia M., Olson, James M., Mehlin, Christopher, Walter, Roland B.

Get full text

Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330 by Laszlo, George S, Beddoe, Mary E, Godwin, Colin D, Bates, Olivia M, Gudgeon, Chelsea J, Harrington, Kimberly H, Walter, Roland B

Get full text

Mapping trait versus species turnover reveals spatiotemporal variation in functional redundancy and network robustness in a plant‐pollinator community by Cantwell‐Jones, Aoife, Larson, Keith, Ward, Alan, Bates, Olivia K., Cox, Tara, Gibbons, Charlotte, Richardson, Ryan, Al‐Hayali, Abdullah M. R., Svedin, Johan, Aronsson, Max, Brannlund, Frida, Tylianakis, Jason M., Johansson, Jacob, Gill, Richard J.

“…Functional overlap among species (redundancy) is considered important in shaping competitive and mutualistic interactions that determine how communities…”
Get full text

The Bruton’s tyrosine kinase inhibitor ibrutinib abrogates bispecific antibody‐mediated T‐cell cytotoxicity by Godwin, Colin D., Bates, Olivia M., Garling, Eliotte E., Beddoe, Mary E., Laszlo, George S., Walter, Roland B.

Get full text

The CD33 splice isoform lacking exon 2 as therapeutic target in human acute myeloid leukemia by Godwin, Colin D., Laszlo, George S., Wood, Brent L., Correnti, Colin E., Bates, Olivia M., Garling, Eliotte E., Mao, Zhengwei J., Beddoe, Mary E., Lunn, Margaret C., Humbert, Olivier, Kiem, Hans-Peter, Walter, Roland B.

Get full text

Targeting the membrane-proximal C2-set domain of CD33 for improved CD33-directed immunotherapy by Godwin, Colin D., Laszlo, George S., Fiorenza, Salvatore, Garling, Eliotte E., Phi, Tinh-Doan, Bates, Olivia M., Correnti, Colin E., Hoffstrom, Benjamin G., Lunn, Margaret C., Humbert, Olivier, Kiem, Hans-Peter, Turtle, Cameron J., Walter, Roland B.

“…There is increasing interest in targeting CD33 in malignant and non-malignant disorders. In acute myeloid leukemia, longer survival with the CD33 antibody-drug…”
Get full text

Anti-apoptotic BCL-2 family proteins confer resistance to calicheamicin-based antibody-drug conjugate therapy of acute leukemia by Godwin, Colin D., Bates, Olivia M., Jean, Sae Rin, Laszlo, George S., Garling, Eliotte E., Beddoe, Mary E., Cardone, Michael H., Walter, Roland B.

Get full text

Anti-Apoptotic BCL-2 Family Members Confer Resistance to Calicheamicin-Based Antibody-Drug Conjugate Therapy of Acute Leukemia by Godwin, Colin D., Bates, Olivia M., Jean, Sae Rin, Laszlo, George S., Garling, Eliotte E., Beddoe, Mary E., Cardone, Michael H., Walter, Roland B.

“…BACKGROUND: With gemtuzumab ozogamicin (GO; targeting CD33) and inotuzumab ozogamicin (IO; targeting CD22), 2 antibody-drug conjugates delivering a toxic…”
Get full text

Bilingual Cognition and Growth Mindset: A Review of Cognitive Flexibility and Its Implications for Dual Language Education by Kandice Grote, Emily Russell, Olivia Bates, Rosemary Gonzalez

“…The United States has seen an increase in cultural and linguistic diversity of student populations. Policy makers have looked toward existing research in dual…”
Get full text

Bispecific Anti-CD123 x Anti-CD3 Adaptir™ Molecules APVO436 and APVO437 Have Broad Activity Against Primary Human AML Cells In Vitro by Godwin, Colin D., Bates, Olivia M., Laszlo, George S., Gottschalk, Rebecca, Comeau, Michael R., Hoyos, Gabriela H., Walter, Roland B.

“…Background: The IL-3 receptor CD123 is an attractive target for antibody-based therapies in acute myeloid leukemia (AML) because of its frequent expression on…”
Get full text

Phosphoinositide 3-kinase inhibitors, including idelalisib, overcome P-glycoprotein-mediated resistance to gemtuzumab ozogamicin in human acute myeloid leukemia cells by Godwin, Colin, Bates, Olivia, Laszlo, George, Walter, Roland

Get full text